fluopyramide[18F]

氟[18F]吡酰胺

Report date: 2025/11/27 15:48:21

NME

Base Information

Drug Namefluopyramide[18F]

Drug Alias NameN/A

ClassificationRadiation-emitting products > Radioactive diagnostic agentSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Fluorine > 18F

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsContrast agentsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaPhase 2 Clinical

Originator CompaniesHta Co Ltd

China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHta Co Ltd

Inactive CompaniesN/A

Active IndicationsContrast agentsMelanoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A